Companies in the oncology sector developing innovative solutions and technologies.
Explore 295 recently funded oncology companies with verified founder contact information and fundraising data.
OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.
Hemerion is focused on creating innovative cancer treatments.
OSE Immunotherapeutics is an integrated biotechnology company focused on inflammatory disease and cancer treatment.
YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
iCellate is a Swedish research and development company focused on cancer research and detection products.
Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.
Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
The Princess Margaret Cancer Foundation assists communities in raising funds to advance cancer research and set new standards of care.
Reboot Rx is a nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments.
Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.
Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.
Araris Biotech is a biotechnology company that develops antibody-drug conjugates for efficient payload attachment.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 295 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked